These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 794620)

  • 21. [Current trends in drug therapy of cerebral ictus].
    Foglia M; Repaci G; Mazzei V; Carulli E; Mapelli A
    Arch Sci Med (Torino); 1978; 135(3):417-22. PubMed ID: 708093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of cerebral deficiency syndrome in latent heart insufficiency].
    Mayerhofer CH
    ZFA (Stuttgart); 1977 Mar; 53(8):453-6. PubMed ID: 324166
    [No Abstract]   [Full Text] [Related]  

  • 23. [On the encephalotrophic action of hydergine. Clinical study].
    Garagnani Sciarretta B; Rimondini S; Martelli A
    Minerva Med; 1974 Aug; 65(59):3090-8. PubMed ID: 4214406
    [No Abstract]   [Full Text] [Related]  

  • 24. Use of Redergam (Latergal) in vascular diseases.
    Kovács E
    Ther Hung; 1986; 34(4):238-42. PubMed ID: 3449979
    [No Abstract]   [Full Text] [Related]  

  • 25. Use of dihydro-ergotoxine-methanesulphonate in senile cerebral circulatory disorders and hypertension.
    Kovách G
    Ther Hung; 1986; 34(1):21-5. PubMed ID: 3447297
    [No Abstract]   [Full Text] [Related]  

  • 26. [Further progress in the treatment of the coronary disease].
    Pillen D
    Med Welt; 1976 Mar; 27(12):581-5. PubMed ID: 772355
    [No Abstract]   [Full Text] [Related]  

  • 27. [Indications for and effects of vasodilating agents, especially in cerebral and peripheral vascular sclerosis].
    Offerhaus L
    Ned Tijdschr Geneeskd; 1981 Feb; 125(6):228-34. PubMed ID: 7207673
    [No Abstract]   [Full Text] [Related]  

  • 28. [Determinants estimating cerebral functions after long term therapy with hydergin].
    Herzfeld U; Christian W; Ronge J; Wittgen M
    Arztl Forsch; 1972 Jun; 26(6):215-28. PubMed ID: 4626216
    [No Abstract]   [Full Text] [Related]  

  • 29. [Comparative trials of various therapeutics relating to cerebral vessels].
    Brion S; Guérin R
    Nouv Presse Med; 1975 Aug 30-Sep 6; 4(28):2035-6. PubMed ID: 1101201
    [No Abstract]   [Full Text] [Related]  

  • 30. [Therapeutic effectiveness and safety of dihydroergocristine. A study of 9,702 patients].
    Mailland F; Zottino G
    Fortschr Med; 1986 Mar; 104(11):239-42. PubMed ID: 3084366
    [No Abstract]   [Full Text] [Related]  

  • 31. [Cerebrovascular disorders in severely sick patients--experience with Card Progresin].
    Osterloh U
    Z Allgemeinmed; 1971 Nov; 47(32):1709-12. PubMed ID: 5137904
    [No Abstract]   [Full Text] [Related]  

  • 32. [Dihydroergotoxine mesylate in chronic cerebrovascular insufficiency: spectral EEG analysis and neuropsychological correlates].
    Moglia A; Bono G; Sinforiani E; Alfonsi E; Zandrini C; Pistarini C; Arrigo A; Franch F
    Farmaco Prat; 1983 Feb; 38(2):97-102. PubMed ID: 6832350
    [No Abstract]   [Full Text] [Related]  

  • 33. [Evaluation of the effectiveness of dihydroergotoxine (DHET) in the treatment of chronic cerebral ischemia syndromes in elderly patients].
    Derejczyk J; Panuś K
    Wiad Lek; 1986 Jun; 39(12):818-24. PubMed ID: 3535261
    [No Abstract]   [Full Text] [Related]  

  • 34. [The use of Ergocomb in symptoms of cerebrovascular insufficiency].
    Pöthig D; Sauer I; Hansen H; Weidnitzer M
    Z Alternsforsch; 1983; 38(6):443-9. PubMed ID: 6659572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of cerebral circulatory insufficiency in latent cardiac insufficiency].
    Wille T
    Med Welt; 1970 Jan; 2():80-3. PubMed ID: 4392336
    [No Abstract]   [Full Text] [Related]  

  • 36. [A multicenter trial of treatment with slow-release dihydroergotoxine in chronic senile cerebral insufficiency].
    Franchi F; Di Ruvo R; Guggino G; Mazzanti A; Genga A; Cucinotta D
    G Clin Med; 1982 Jul; 63(7):465-81. PubMed ID: 6757035
    [No Abstract]   [Full Text] [Related]  

  • 37. [Experience with using sinepress in hypertension].
    Orlov VM; Ivashchuk AG; Troshina EV; Iartsev SS; Gorokhovskaia GN
    Klin Med (Mosk); 1987 Apr; 65(4):30-1. PubMed ID: 3298841
    [No Abstract]   [Full Text] [Related]  

  • 38. [Eutergin in the treatment of chronic cerebrovascular disturbance patterns (author's transl)].
    Prosenz P
    Aktuelle Gerontol; 1980 Jun; 10(6):245-51. PubMed ID: 6109460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hypertension in old age. Treatment with Hydergin].
    Dennler HJ; Weidinger G
    ZFA (Stuttgart); 1983 Oct; 59(29):1646-9. PubMed ID: 6359752
    [No Abstract]   [Full Text] [Related]  

  • 40. [The importance of cardiac support in the treatment of cerebral circulatory disorders. Lanicor].
    Internist Prax; 1965; 5(3):493-4. PubMed ID: 5830704
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.